We found that the coinjection of either Igf2bp1, Igf2bp2, or Igf2bp3 in tandem with NRASG12V efficiently rescued cancers in Lin28a/Lin28b/Tp53-TKO mice (Supplemental Figure 5B). This evidence concerns the gene TP53 and cancer.